Jynarque 15MG/45MG for patient E.W.
Ended Awarded
- Contract number
- 36C24621N0694
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,304
Award facts
- Contract value 100% obligated
- $10,303.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Richmond, VA 23249, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a $10,303.55 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 15mg/45mg medication for patient E.W. The award was issued on March 26, 2021, with an ultimate completion date of April 2, 2021. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Richmond, Virginia.
This delivery order represents a task order issued against Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $83.3 million with a completion date of March 26, 2026. Jynarque (tolvaptan) is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, has established itself as a primary supplier of specialty medications to the VA through multiple Indefinite Delivery Vehicles across various Veterans Integrated Service Networks. The firm fixed-price structure and standardized delivery order process reflect the streamlined procurement mechanism that enables VA facilities nationwide to efficiently obtain critical pharmaceutical treatments for veterans.
Quick answers
Who was awarded contract 36C24621N0694?
36C24621N0694 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on March 26, 2021.
How much is contract 36C24621N0694 worth?
The government has obligated $10,304 on 36C24621N0694.
Is contract 36C24621N0694 an order under another contract?
Yes. 36C24621N0694 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24621N0694 competed?
The extent of competition for 36C24621N0694 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award